Related references
Note: Only part of the references are listed.Screening of over 100 drugs in horse urine using automated on-line solid-phase extraction coupled to liquid chromatography-high resolution mass spectrometry for doping control
W. H. Kwok et al.
JOURNAL OF CHROMATOGRAPHY A (2017)
Alkaloids from Veratrum taliense Exert Cardiovascular Toxic Effects via Cardiac Sodium Channel Subtype 1.5
Gan Wang et al.
TOXINS (2016)
Untargeted screening of unknown xenobiotics and potential toxins in plasma of poisoned patients using high-resolution mass spectrometry: Generation of xenobiotic fingerprint using background subtraction
Chang Chen et al.
ANALYTICA CHIMICA ACTA (2016)
High-resolution mass spectrometry in toxicology: current status and future perspectives
H. H. Maurer et al.
ARCHIVES OF TOXICOLOGY (2016)
Metabolomics: beyond biomarkers and towards mechanisms
Caroline H. Johnson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
The application of high-resolution mass spectrometry-based data-mining tools in tandem to metabolite profiling of a triple drug combination in humans
Jie Xing et al.
ANALYTICA CHIMICA ACTA (2015)
Applications of mass spectrometry in drug metabolism: 50 years of progress
Bo Wen et al.
DRUG METABOLISM REVIEWS (2015)
Liquid Chromatography High-Resolution TOF Analysis: Investigation of MSE for Broad-Spectrum Drug Screening
Nandkishor S. Chindarkar et al.
CLINICAL CHEMISTRY (2014)
Ultraperformance Liquid Chromatography-Mass Spectrometry Based Comprehensive Metabolomics Combined with Pattern Recognition and Network Analysis Methods for Characterization of Metabolites and Metabolic Pathways from Biological Data Sets
Ai-hua Zhang et al.
ANALYTICAL CHEMISTRY (2013)
An integral strategy toward the rapid identification of analogous nontarget compounds from complex mixtures
Liang Wu et al.
JOURNAL OF CHROMATOGRAPHY A (2013)
Testing an alternative search algorithm for compound identification with the 'Wiley Registry of Tandem Mass Spectral Data, MSforID'
Herbert Oberacher et al.
JOURNAL OF MASS SPECTROMETRY (2013)
Xenobiotic Metabolomics: Major Impact on the Metabolome
Caroline H. Johnson et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Metabolomic study of insomnia and intervention effects of Suanzaoren decoction using ultra-performance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry
Bo Yang et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2012)
Identification of Known Unknowns Utilizing Accurate Mass Data and ChemSpider
James L. Little et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2012)
Ingenuity pathways analysis of urine metabolomics phenotypes toxicity of Chuanwu in Wistar rats by UPLC-Q-TOF-HDMS coupled with pattern recognition methods
Hui Dong et al.
MOLECULAR BIOSYSTEMS (2012)
LC-MS-based metabolomics in profiling of drug metabolism and bioactivation
Feng Li et al.
ACTA PHARMACEUTICA SINICA B (2012)
Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology
Frank T. Peters
CLINICAL BIOCHEMISTRY (2011)
Metabolomic Analysis Reveals Novel Isoniazid Metabolites and Hydrazones in Human Urine
Feng Li et al.
DRUG METABOLISM AND PHARMACOKINETICS (2011)
Metabolomic Profiling to Identify Potential Serum Biomarkers for Schizophrenia and Risperidone Action
Jiekun Xuan et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Acylcarnitines: Role in brain
Lauren L. Jones et al.
PROGRESS IN LIPID RESEARCH (2010)
An algorithm for thorough background subtraction from high-resolution LC/MS data: application to the detection of troglitazone metabolites in rat plasma, bile, and urine
Haiying Zhang et al.
JOURNAL OF MASS SPECTROMETRY (2008)
Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology
Hans H. Maurer
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2007)
LC-MS-based metabolomics in drug metabolism
Chi Chen et al.
DRUG METABOLISM REVIEWS (2007)
Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment
DR Evans et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2003)
Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics
MM Khan et al.
SCHIZOPHRENIA RESEARCH (2002)
Share Paper
